Mitchell Sheona M, Pedersen Heather N, Eng Stime Evelyn, Sekikubo Musa, Moses Erin, Mwesigwa David, Biryabarema Christine, Christilaw Jan, Byamugisha Josaphat K, Money Deborah M, Ogilvie Gina S
University of British Columbia, Vancouver, BC, Canada.
Makerere University, Kampala, Uganda.
BMC Womens Health. 2017 Jan 13;17(1):4. doi: 10.1186/s12905-016-0360-0.
Women living with HIV (WHIV) are disproportionately impacted by cervical dysplasia and cancer. The burden is greatest in low-income countries where limited or no access to screening exists. The goal of this study was to describe knowledge and intentions of WHIV towards HPV self-collection for cervical cancer screening, and to report on factors related to HPV positivity among women who participated in testing.
A validated survey was administered to 87 HIV positive women attending the Kisenyi Health Unit aged 30-69 years old, and data was abstracted from chart review. At a later date, self-collection based HPV testing was offered to all women. Specimens were tested for high risk HPV genotypes, and women were contacted with results and referred for care. Descriptive statistics, Chi Square and Fischer-exact statistical tests were performed.
The vast majority of WHIV (98.9%) women did not think it necessary to be screened for cervical cancer and the majority of women had never heard of HPV (96.4%). However, almost all WHIV found self-collection for cervical cancer screening to be acceptable. Of the 87 WHIV offered self-collection, 40 women agreed to provide a sample at the HIV clinic. Among women tested, 45% were oncogenic HPV positive, where HPV 16 or 18 positivity was 15% overall.
In this group of WHIV engaged in HIV care, there was a high prevalence of oncogenic HPV, a large proportion of which were HPV genotypes 16 or 18, in addition to low knowledge of HPV and cervical cancer screening. Improved education and cervical cancer screening for WHIV are sorely needed; self-collection based screening has the potential to be integrated with routine HIV care in this setting.
感染艾滋病毒的女性(WHIV)受宫颈发育异常和癌症的影响尤为严重。在低收入国家,这种负担最为沉重,因为这些国家获得筛查的机会有限或根本没有。本研究的目的是描述感染艾滋病毒的女性对用于宫颈癌筛查的人乳头瘤病毒(HPV)自我采样的了解和意愿,并报告参与检测的女性中与HPV阳性相关的因素。
对87名年龄在30 - 69岁、前往基森伊健康单位就诊的艾滋病毒阳性女性进行了一项经过验证的调查,并从病历审查中提取数据。之后,为所有女性提供基于自我采样的HPV检测。对样本进行高危HPV基因型检测,并将结果告知女性并转诊接受治疗。进行了描述性统计、卡方检验和费舍尔精确统计检验。
绝大多数感染艾滋病毒的女性(98.9%)认为没有必要进行宫颈癌筛查,并且大多数女性从未听说过人乳头瘤病毒(96.4%)。然而,几乎所有感染艾滋病毒的女性都认为用于宫颈癌筛查的自我采样是可以接受的。在87名被提供自我采样的感染艾滋病毒的女性中,40名女性同意在艾滋病毒诊所提供样本。在接受检测的女性中,45%的人致癌性HPV呈阳性,其中HPV 16或18阳性的总体比例为15%。
在这组接受艾滋病毒护理的感染艾滋病毒的女性中,致癌性HPV的患病率很高,其中很大一部分是HPV 16或18基因型,此外对HPV和宫颈癌筛查的了解程度较低。迫切需要改善对感染艾滋病毒的女性的教育和宫颈癌筛查;基于自我采样的筛查有可能在这种情况下与常规艾滋病毒护理相结合。